Acasti Pharma Inc.$3.37 %
Analyst Rating: Hold
Stock Details
CEO
Prashant Kohli
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
32
Address
3009 boulevard de la Concorde East, Laval, QC, H7E 2B5
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Acasti Pharma Inc. $3.37
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results